Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Aris I. Giotakis, Annette Runge, József Dudas, Rudolf Glueckert, Timo Gottfried, Volker H. Schartinger, Johanna Klarer, Avneet Randhawa, Eleonora Caimmi & Herbert Riechelmann. (2023) Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report. BMC Cancer 23:1.
Crossref
Crossref
Deepti Sharma, Abi M. Thomas & George Koshy. (2023) Tumor Infiltrating Lymphocytes as Immunebiomarkers in Oral Cancer: An Update. Journal of Cancer Research Updates 12, pages 33-39.
Crossref
Crossref
Katarzyna Starska-Kowarska. (2023) The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. Cancers 15:6, pages 1642.
Crossref
Crossref
Juan P. Rodrigo, Mario Sánchez-Canteli, Asterios Triantafyllou, Remco de Bree, Antti A. Mäkitie, Alessandro Franchi, Henrik Hellquist, Nabil F. Saba, Göran Stenman, Robert P. Takes, Cristina Valero, Nina Zidar & Alfio Ferlito. (2023) Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers 15:3, pages 802.
Crossref
Crossref
Peng Shen, Bo Qiao, Nenghao Jin & Shuyan Wang. (2022) Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study. Investigational New Drugs 40:6, pages 1282-1289.
Crossref
Crossref
Qimin Zhou, Ouyang Yuan, Hongtu Cui, Tao Hu, Gary Guishan Xiao, Jiao Wei, Honglei Zhang & Chengjun Wu. (2022) Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
D. Rischin, H. Mehanna, R.J. Young, M. Bressel, J. Dunn, J. Corry, P. Soni, T. Fulton-Lieuw, G. Iqbal, L. Kenny, S. Porceddu, C. Wratten, M. Robinson & B.J. Solomon. (2022) Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials. Annals of Oncology 33:8, pages 804-813.
Crossref
Crossref
Thomas Duhen, Michael J. Gough, Rom S. Leidner & Sasha E. Stanton. (2022) Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes. Frontiers in Oral Health 3.
Crossref
Crossref
Yi Jin, Zhanwang Wang, Weizhi Tang, Muxing Liao, Xiangwei Wu & Hui Wang. (2022) An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Changxiang Huan & Jiaxin Gao. (2022) A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma. Mathematical Biosciences and Engineering 19:12, pages 12127-12145.
Crossref
Crossref
Kedar Kirtane & Christine H. Chung. 2023. Immunotherapy for Head and Neck Cancer. Immunotherapy for Head and Neck Cancer
135
147
.
Hirofumi Shibata, Shin Saito & Ravindra Uppaluri. (2021) Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Huanhuan Wang, Qin Zhao, Yuyu Zhang, Qihe Zhang, Zhuangzhuang Zheng, Shiyu Liu, Zijing Liu, Lingbin Meng, Ying Xin & Xin Jiang. (2021) Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus. Frontiers in Immunology 12.
Crossref
Crossref
Vanesa Gutiérrez Calderón, Alexandra Cantero González, Laura Gálvez Carvajal, Yolanda Aguilar Lizarralde & Antonio Rueda Domínguez. (2021) Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model. Therapeutic Advances in Medical Oncology 13, pages 175883592098406.
Crossref
Crossref
Barbara Azzimonti, Luca Raimondo, Diletta Francesca Squarzanti, Tiziana Rosso, Paola Zanetta, Paolo Aluffi Valletti, Luigi Chiusa, Laura Masini, Giancarlo Pecorari, Mario Airoldi, Marco Krengli, Mirella Giovarelli & Guido Valente. (2021) Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma. Annals of Medicine 53:1, pages 541-550.
Crossref
Crossref
Marij J. P. Welters, Saskia J. Santegoets & Sjoerd H. van der Burg. (2020) The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Barbara Seliger, Chiara Massa, Bo Yang, Daniel Bethmann, Matthias Kappler, Alexander Walter Eckert & Claudia Wickenhauser. (2020) Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 21:19, pages 7032.
Crossref
Crossref
Renata Ferrarotto, Diana Bell, Maria L. Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, Danice K. Torman, Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson & Neil D. Gross. (2020) Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results. Clinical Cancer Research 26:13, pages 3211-3219.
Crossref
Crossref
Julian Biau & Jean Bourhis. (2020) Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?. Current Opinion in Oncology 32:3, pages 196-202.
Crossref
Crossref
Emma J. de Ruiter, Reinout H. de Roest, Ruud H. Brakenhoff, C. René Leemans, Remco de Bree, Chris H. J. Terhaard & Stefan M. Willems. (2020) Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors. Cancer Immunology, Immunotherapy 69:4, pages 581-591.
Crossref
Crossref
Hui Tang, Xiang Zhou, Yu Ye, Yi Zhou, Chengyu Wu & Yan Xu. (2020) The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis. Pathology - Research and Practice 216:1, pages 152768.
Crossref
Crossref
Valerie Cristina, Ruth Gabriela Herrera-Gómez, Petr Szturz, Vittoria Espeli & Marco Siano. (2019) Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 20:21, pages 5399.
Crossref
Crossref
Hui-Ching Wang, Leong-Perng Chan & Shih-Feng Cho. (2019) Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 9.
Crossref
Crossref
Fumihiko Sato, Takeharu Ono, Akihiko Kawahara, Toshihiko Kawaguchi, Hisaichiro Tanaka, Kazuhide Shimamatsu, Tatsuyuki Kakuma, Jun Akiba, Hirohito Umeno & Hirohisa Yano. (2019) Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment. Journal of Clinical Pathology 72:8, pages 542-549.
Crossref
Crossref
Sanjib Chaudhary, Koelina Ganguly, Sakthivel Muniyan, Ramesh Pothuraju, Zafar Sayed, Dwight T Jones, Surinder K Batra & Muzafar A Macha. (2019) Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. JNCI: Journal of the National Cancer Institute 111:3, pages 233-244.
Crossref
Crossref
Bianca Cioni, Ekaterina S. Jordanova, Erik Hooijberg, Rianne van der Linden, Renee X. de Menezes, Katherine Tan, Stefan Willems, Joris B. W. Elbers, Annegien Broeks, Andries M. Bergman, Charlotte L. Zuur & Jan Paul de Boer. (2018) HLA class II expression on tumor cells and low numbers of tumor‐associated macrophages predict clinical outcome in oropharyngeal cancer. Head & Neck 41:2, pages 463-478.
Crossref
Crossref
M. Oliva, A. Spreafico, M. Taberna, L. Alemany, B. Coburn, R. Mesia & L.L. Siu. (2019) Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Annals of Oncology 30:1, pages 57-67.
Crossref
Crossref
Sonja Ludwig, Priyanka Sharma, Marie-Nicole Theodoraki, Monika Pietrowska, Saigopalakrishna S. Yerneni, Stephan Lang, Soldano Ferrone & Theresa L. Whiteside. (2018) Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines. Frontiers in Oncology 8.
Crossref
Crossref
Benjamin Solomon, Richard J. Young & Danny Rischin. (2018) Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Seminars in Cancer Biology 52, pages 228-240.
Crossref
Crossref
Benjamin Solomon, Richard J. Young, Mathias Bressel, Damien Urban, Shona Hendry, Alesha Thai, Christopher Angel, Afaf Haddad, Marcin Kowanetz, Tsien Fua, June Corry, Stephen Fox & Danny Rischin. (2018) Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma. Cancer Immunology Research 6:3, pages 295-304.
Crossref
Crossref